DBPR-114

N/A

Report date: 2022/01/14 13:23:58

NME

Base Information

Drug NameDBPR-114

Drug Alias NameDBPR-114

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionCheckpoint kinase 2 inhibitorsSerine/threonine-protein kinase Aurora-A inhibitorsSerine/threonine-protein kinase Aurora-B inhibitors +[4]

TargetsCheckpoint kinase 2Serine/threonine-protein kinase Aurora-ASerine/threonine-protein kinase Aurora-B +[4]

Therapy Area/IndicationsNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusPhase 1 Clinical

Highest Status in ChinaN/A

Originator CompaniesNational Health Research Institutes

China Registration ClassN/A

Develop Information

Active CompaniesNational Health Research Institutes

Inactive CompaniesN/A

Active IndicationsNeoplasms

Inactive IndicationsN/A

Other Information

ATC CodeN/A